Vandria

BiotechnologySeries AEpalinges, Switzerlandvandria.com

Latest round

Series A

Last raised

Aug 2024

Total raised

$33M

Investors

3

About Vandria

Based in Epalinges, Switzerland, Vandria SA is a biopharmaceutical company that develops small molecule mitophagy inducers to treat age-related and chronic diseases. The company was co-founded by Johan Auwerx and Patrick Aebischer. The company has created and patented new small molecules that focus on muscle tissue and the central nervous system (CNS). Vandria is in the process of preparing for IND (investigational new drug) submission for lead candidates that have demonstrated positive results both in the laboratory and in living organisms. The targeted diseases include mild cognitive impairment, ALS (Amyotrophic Lateral Sclerosis), Parkinson's disease (PD) for the CNS, and sporadic body myositis and sarcopenia for muscle-related conditions..

Who invested in Vandria

3 investors across 2 rounds

See all investors in Vandria

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Aug 21, 2024

    Amount

    $12M

    Investors

    Locked

  2. Series A

    Dec 14, 2023

    Amount

    $21M

    Investors

    Locked

Questions about Vandria

Who invested in Vandria?

Vandria has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Vandria raised?

Vandria has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Vandria last raise money?

Vandria's most recent round on record is a Series A, in Aug 2024.

What does Vandria do?

Based in Epalinges, Switzerland, Vandria SA is a biopharmaceutical company that develops small molecule mitophagy inducers to treat age-related and chronic diseases.

Where is Vandria headquartered?

Vandria is headquartered in Epalinges, Switzerland.

Which VCs invest in companies like Vandria?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Vandria's stage. Their profiles are linked below.

Raising like Vandria? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.